Q3 2026 13F filing
Updated 6 days ago37 disclosed positions worth $1.3B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | R RELAY THERAPEUTICS INC | $216.6M | 12.00M | 16.78% | — |
| 2 | E ENLIVEN THERAPEUTICS INC | $150.1M | 3.27M | 11.63% | — |
| 3 | A ALKERMES PLC | $116.5M | 2.88M | 9.03% | — |
| 4 | A ALTO NEUROSCIENCE INC | $69.5M | 2.72M | 5.39% | — |
| 5 | S SPYRE THERAPEUTICS INC | $62.3M | 700.0K | 4.83% | — |
| 6 | A AMYLYX PHARMACEUTICALS INC | $58.2M | 2.00M | 4.51% | — |
| 7 | L LB PHARMACEUTICALS INC | $49.2M | 1.28M | 3.81% | — |
| 8 | ? N/A DAMORA THERAPEUTICS INC | $41.3M | 1.94M | 3.20% | — |
| 9 | C COGENT BIOSCIENCES INC | $40.5M | 1.26M | 3.14% | — |
| 10 | T TYRA BIOSCIENCES INC | $37.7M | 1.73M | 2.92% | — |
| 11 | C CELLDEX THERAPEUTICS INC NEW | $32.4M | 1.00M | 2.51% | — |
| 12 | P PHARVARIS N V | $29.3M | 925.0K | 2.27% | — |
| 13 | ? N/A SURROZEN INC | $28.5M | 885.0K | 2.21% | — |
| 14 | K KORSANA BIOSCIENCES INC | $28.1M | 877.0K | 2.17% | — |
| 15 | S SAGIMET BIOSCIENCES INC | $27.2M | 2.76M | 2.11% | — |
| 16 | D DEFINIUM THERAPEUTICS INC | $26.6M | 700.0K | 2.06% | — |
| 17 | A ADARX PHARMACEUTICALS INC | $25.1M | 1.26M | 1.95% | — |
| 18 | E EDITAS MEDICINE INC | $22.8M | 8.89M | 1.77% | — |
| 19 | E ENTERA BIO LTD | $21.4M | 7.35M | 1.66% | — |
| 20 | ? N/A ATTOVIA THERAPEUTICS INC | $19.9M | 1.16M | 1.54% | — |
| 21 | A AGENUS INC | $19.7M | 1.99M | 1.53% | — |
| 22 | K KYMERA THERAPEUTICS INC | $19.6M | 175.0K | 1.52% | — |
| 23 | I INFLARX NV | $16.7M | 9.27M | 1.29% | — |
| 24 | A AVALO THERAPEUTICS INC | $15.6M | 1.02M | 1.21% | — |
| 25 | ? N/A AN2 THERAPEUTICS INC | $15.6M | 2.93M | 1.21% | — |
| 26 | C CENTURY THERAPEUTICS INC | $14.9M | 8.70M | 1.15% | — |
| 27 | Z ZURA BIO LTD | $13.5M | 3.25M | 1.05% | — |
| 28 | I INHIBIKASE THERAPEUTICS INC | $11.1M | 5.40M | 0.86% | — |
| 29 | A ASSEMBLY BIOSCIENCES INC | $10.9M | 461.9K | 0.84% | — |
| 30 | P PEPGEN INC | $10.8M | 4.47M | 0.84% | — |
| 31 | S SAB BIOTHERAPEUTICS INC | $9.1M | 2.87M | 0.70% | — |
| 32 | R RELMADA THERAPEUTICS INC | $8.9M | 2.35M | 0.69% | — |
| 33 | R RESEARCH ALLIANCE CORP IV | $5.8M | 500.0K | 0.45% | — |
| 34 | ? N/A HELIX ACQUISITION CORP III | $5.3M | 500.0K | 0.41% | — |
| 35 | J JATT III ACQUISITION CORP | $4.4M | 400.0K | 0.34% | — |
| 36 | ? N/A TCGX ACQUISITION CORP | $3.8M | 300.0K | 0.29% | — |
| 37 | L LEONABIO INC | $1.7M | 464.4K | 0.13% | — |